For the year ending 2025-12-31, MPT had $194,110K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Depreciation and amortization | 272,817 | - | - | - |
| Amortization of deferred financing costs and debt discount | 26,283 | - | - | - |
| Straight-line rent revenue and other | 158,172 | - | - | - |
| Stock / (unit)-based compensation expense | 25,746 | - | - | - |
| (gain) loss on sale of real estate | 5,545 | - | - | - |
| Real estate and other impairment charges, net | 193,947 | - | - | - |
| Straight-line rent and other write-off | 11,054 | - | - | - |
| Debt refinancing and unutilized financing (benefit) costs | 3,629 | - | - | - |
| Tax rate changes and other | -11,231 | - | - | - |
| Non-cash fair value adjustments | 106,442 | - | - | - |
| Other adjustments | -7,580 | - | - | - |
| Interest and rent receivables | -7,111 | - | - | - |
| Other assets | -14,971 | - | - | - |
| Accounts payable and accrued expenses | 21,680 | - | - | - |
| Deferred revenue | -9,608 | - | - | - |
| Profit Loss | -275,937 | -2,408,287 | -556,092 | 903,819 |
| Depreciation and amortization | - | 453,749 | 616,127 | 345,577 |
| Amortization of deferred financing costs and debt discount | - | 17,348 | 15,775 | 17,045 |
| Straight-line rent revenue and other | - | 172,765 | 233,703 | 282,504 |
| Stock / (unit)-based compensation expense | - | 32,976 | 33,250 | 49,421 |
| (gain) loss on sale of real estate | - | 478,693 | -1,815 | 536,755 |
| Net loss | -275,937 | - | - | - |
| Real estate and other impairment charges, net | - | 1,825,402 | 376,907 | 268,375 |
| Net cash provided by operating activities | 230,767 | - | - | - |
| Equity interest real estate impairment | - | 410,790 | - | - |
| Net proceeds from sale of real estate | 120,550 | 1,854,077 | 897,500 | 2,185,574 |
| Straight-line rent and other write-off | - | 2,514 | 649,911 | - |
| Principal received on loans receivable | - | - | 501,630 | 53,322 |
| Principal received from sale and repayment of loans receivable | 116,309 | 214,416 | - | - |
| Write-off of unbilled rent and other | - | - | - | 34,605 |
| Debt refinancing and unutilized financing (benefit) costs | - | 4,292 | -285 | - |
| Investment in loans receivable | 205,752 | 420,324 | 250,223 | 207,542 |
| Debt refinancing and unutilized financing costs | - | - | - | 9,452 |
| Tax rate changes and other | - | 5,119 | -167,332 | - |
| Construction in progress and other | 80,003 | - | - | - |
| Tax rate and other changes | - | - | - | 10,697 |
| Non-cash revenue from debt and equity securities received | - | - | 81,706 | - |
| Non-cash fair value adjustments | - | 563,666 | - | - |
| Capital additions and other investments, net | 73,753 | - | - | - |
| Other adjustments | - | -4,975 | 23,870 | -6,108 |
| Cash paid for acquisitions and other related investments-Mpt Operating Partnership LP | 142,089 | - | - | - |
| Interest and rent receivables | - | -2,778 | 141,729 | 116,420 |
| Net proceeds from sale of real estate-Mpt Operating Partnership LP | 120,550 | - | - | - |
| Other assets | - | 36,109 | -13,750 | 4,029 |
| Principal received from sale and repayment of loans receivable-Mpt Operating Partnership LP | 116,309 | - | - | - |
| Accounts payable and accrued expenses | - | 23,481 | -4,599 | 33,576 |
| Investment in loans receivable-Mpt Operating Partnership LP | 205,752 | - | - | - |
| Deferred revenue | - | -5,753 | 7,567 | 43 |
| Construction in progress and other-Mpt Operating Partnership LP | 80,003 | - | - | - |
| Net cash provided by operating activities | - | 245,483 | 505,786 | 739,010 |
| Capital additions and other investments, net-Mpt Operating Partnership LP | 73,753 | - | - | - |
| Construction in progress and other | - | 79,788 | 114,425 | 109,237 |
| Cash paid for acquisitions and other related investments | 142,000 | 105,618 | 235,187 | 1,332,962 |
| Proceeds from sale and return of equity investments | - | 11,656 | 12,430 | 14,295 |
| Net cash (used for) provided by investing activities | -264,738 | - | - | - |
| Capital additions and other investments, net | - | 156,078 | 294,167 | 207,394 |
| Proceeds from term debt | 2,512,970 | - | - | - |
| Net cash provided by investing activities | - | 1,318,341 | 517,558 | 396,056 |
| Payments of term debt | 2,252,731 | - | - | - |
| Proceeds from term debt | - | 804,188 | - | 128,536 |
| Revolving credit facilities, net | 241,530 | - | - | - |
| Payments of term debt | - | 701,809 | 988,162 | 869,606 |
| Dividends / distribution paid | 193,259 | - | - | - |
| Revolving credit facilities, net | - | -1,131,312 | 567,910 | 203,576 |
| Lease deposits and other obligations to tenants | 3,202 | - | - | - |
| Dividends / distribution paid | - | 321,080 | 615,390 | 698,535 |
| Offering costs | 727 | - | - | - |
| Lease deposits and other obligations to tenants | - | -2,237 | -10,139 | 5,020 |
| Repurchase of common stock / unit | 23,441 | - | - | 17,940 |
| Stock / unit vesting - satisfaction of tax withholdings | 2,474 | 3,805 | 8,079 | 29,922 |
| Payment of debt refinancing and deferred financing costs and other financing activities | -50,585 | - | - | - |
| Other financing activities, payment of debt refinancing and deferred financing costs | - | -127,798 | 13,255 | -53,612 |
| Net cash provided by (used for) financing activities | 228,081 | - | - | - |
| Net cash used for financing activities | - | -1,479,379 | -1,020,327 | -1,342,523 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 194,110 | - | - | - |
| Increase in cash, cash equivalents, and restricted cash for the year | 194,110 | 84,445 | 3,017 | -207,457 |
| Effect of exchange rate changes | 14,712 | -5,224 | 11,397 | -12,887 |
| Cash, cash equivalents, and restricted cash at beginning of year | 335,173 | 255,952 | 241,538 | 461,882 |
| Cash, cash equivalents, and restricted cash at end of year | 543,995 | 335,173 | 255,952 | 241,538 |
MEDICAL PROPERTIES TRUST INC (MPT)
MEDICAL PROPERTIES TRUST INC (MPT)